We stand out among biotech investor relations firms.
Moving swiftly and effectively, we champion your interests as boutique service providers who’ve been in your shoes—and know the people you need to meet. Located in San Diego, with clients from around the world, we can help develop your investor relations strategy. Juniper Point’s clientele stretches from preclinical through commercial-stage, so our services apply to different life cycles in a company’s history.
We’re dedicated to moving your biotech from emerging growth to IPO—and beyond—through our trusted relationships and successful execution.
Meet a team who understands your path forward.
Whether your company is in the biotechnology, life sciences, healthcare, or medical device field, our elite team is exceptionally capable and has extensive relationships throughout the industry and on Wall Street. Juniper Point clients—who are more so our partners—benefit from our in-house functionality and access, while we operate as a nimble, outsourced team.
Finance & Office Lead
Thanks to her 14+ years in office management and accounting, Maria is an adept manager of Juniper Point’s day-to-day operations, including financial reporting. Read more…
Forge Therapeutics“Our goal is to be a leading biotech company in San Diego and by default a significant company in California and possibly nationwide. Juniper Point is helping us achieve this strategic vision.”
Evotec AG“With activities spanning various disease areas, diverse technology platforms and a unique business model, Evotec can be a challenge to communicate. The team at Juniper Point have deep insight into the Pharma and biotech industries and understand our audience’s needs extremely well. Their research and support have helped us significantly increase our visibility with both investors and potential partners in the US.”
Prometheus Biosciences“Amy is a trusted, strategic partner to me and the entire team at Prometheus Biosciences. She filled an internal gap leading IR and communications, helping us raise awareness of the company on Wall Street, close on a cross-over and eventually go public on Nasdaq. I am proud to endorse Juniper Point.”
Heron Therapeutics, Inc. (HRTX)“As a commercial stage company with multiple franchises, Heron has a big responsibility to communicate effectively to our audiences. Amy and the team at Juniper Point have been great for us – they are laser focused on execution and have been key to our successful interactions with the Street over the last several years. I am proud to endorse the firm.”
Need a trusted partner?
From positioning your biotech company in the market to providing creative services, our seasoned team helps your idea stand out—and succeed.